Developmental immunotoxicity (DIT) testing of pharmaceuticals: current practices, state of the science, knowledge gaps, and recommendations.
about
Developmental Immunotoxicity, Perinatal Programming, and Noncommunicable Diseases: Focus on Human StudiesDevelopmental immunotoxicity of chemicals in rodents and its possible regulatory impact.Assessment of health risks resulting from early-life exposures: Are current chemical toxicity testing protocols and risk assessment methods adequate?20 Years of fish immunotoxicology - what we know and where we are.Evaluation of a novel delayed-type hypersensitivity assay to Candida albicans in adult and neonatal rats.
P2860
Developmental immunotoxicity (DIT) testing of pharmaceuticals: current practices, state of the science, knowledge gaps, and recommendations.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Developmental immunotoxicity ( ...... dge gaps, and recommendations.
@en
Developmental immunotoxicity ( ...... dge gaps, and recommendations.
@nl
type
label
Developmental immunotoxicity ( ...... dge gaps, and recommendations.
@en
Developmental immunotoxicity ( ...... dge gaps, and recommendations.
@nl
prefLabel
Developmental immunotoxicity ( ...... dge gaps, and recommendations.
@en
Developmental immunotoxicity ( ...... dge gaps, and recommendations.
@nl
P2093
P2860
P1476
Developmental immunotoxicity ( ...... dge gaps, and recommendations.
@en
P2093
Daniel Wierda
Gary J Chellman
Jacintha Shenton
Joseph R Piccotti
Leigh Ann Burns-Naas
Mark Collinge
Thomas T Kawabata
Wendy J Komocsar
P2860
P304
P356
10.3109/1547691X.2012.661486
P577
2012-03-19T00:00:00Z